814P Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3

M. R. Migden, C. Schmults, N. Khushanlani, A. Guminski, A. L. Chang, K. Lewis, G. Ansstas, S. E. Bowyer, B. G. M. Hughes, D. Schadendorf, B. Modi, L. Dunn, L. Flatz, A. Hauschild, S-Y. Yoo, J. Booth, F. Seebach, I. Lowy, M. G. Fury, D. Rischin

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

7 Citations (Web of Science)
Original languageEnglish
Pages (from-to)S918-S919
Number of pages2
JournalAnnals of Oncology
Volume33
Issue number7
DOIs
Publication statusPublished - Sept 2022
Event2022 Annual Meeting of the European-Society-for-Medical-Oncology - , France
Duration: 9 Sept 202213 Sept 2022

Cite this